Balyasny Asset Management LLC Regeneron Pharmaceuticals, Inc. Transaction History

Balyasny Asset Management LLC

$57.8 Billion
Q1 2025

A detailed history of Balyasny Asset Management LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Balyasny Asset Management LLC holds 33,527 shares of REGN stock, worth $16.4 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

33,527

Previous 1,400 2294.79%

Holding current value

$16.4 Million

Previous $997,000 2032.7%

% of portfolio

0.04%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$634.14 - $744.83 $3 Million - $3.53 Million	4,736 Added 16.45%	33,527 $21.3 Million
Q4 2024 Feb 14, 2025	BUY	$701.85 - $1046.91 $14.5 Million - $21.7 Million	20,705 Added 256.06%	28,791 $20.5 Million
Q3 2024 Nov 14, 2024	BUY	$1024.09 - $1201.76 $624,694 - $733,073	610 Added 8.16%	8,086 $8.5 Million
Q2 2024 Aug 14, 2024	SELL	$883.2 - $1071.19 $1.88 Million - $2.28 Million	-2,126 Reduced 22.14%	7,476 $7.86 Million
Q1 2024 May 13, 2024	SELL	$902.69 - $993.35 $29.2 Million - $32.2 Million	-32,391 Reduced 77.13%	9,602 $9.24 Million
Q4 2023 Feb 14, 2024	BUY	$775.18 - $881.7 $31.1 Million - $35.3 Million	40,065 Added 2078.06%	41,993 $36.9 Million
Q3 2023 Nov 14, 2023	SELL	$692.45 - $844.37 $460,479 - $561,506	-665 Reduced 25.65%	1,928 $1.59 Million
Q2 2023 Aug 14, 2023	BUY	$700.03 - $830.35 $1.82 Million - $2.15 Million	2,593 New	2,593 $1.86 Million
Q4 2022 Feb 14, 2023	BUY	$705.89 - $766.39 $23.6 Million - $25.6 Million	33,457 New	33,457 $24.1 Million
Q2 2022 Aug 15, 2022	BUY	$548.35 - $738.84 $44.3 Million - $59.7 Million	80,763 New	80,763 $47.7 Million
Q3 2021 Nov 15, 2021	SELL	$574.03 - $680.96 $38.4 Million - $45.6 Million	-66,919 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$472.8 - $558.54 $31.6 Million - $37.4 Million	66,919 New	66,919 $37.4 Million
Q4 2020 Feb 16, 2021	SELL	$478.3 - $607.98 $14.6 Million - $18.6 Million	-30,582 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$544.75 - $658.21 $16.7 Million - $20.1 Million	30,582 New	30,582 $17.1 Million
Q4 2019 Feb 14, 2020	SELL	$274.13 - $376.51 $48.3 Million - $66.3 Million	-176,027 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$273.46 - $318.39 $22.7 Million - $26.4 Million	-83,020 Reduced 32.05%	176,027 $48.8 Million
Q2 2019 Aug 14, 2019	BUY	$299.6 - $414.82 $46.4 Million - $64.3 Million	155,008 Added 148.99%	259,047 $81.1 Million
Q1 2019 May 15, 2019	BUY	$372.08 - $439.57 $21.5 Million - $25.4 Million	57,867 Added 125.33%	104,039 $42.7 Million
Q4 2018 Feb 14, 2019	BUY	$335.82 - $403.04 $5.34 Million - $6.41 Million	15,898 Added 52.51%	46,172 $17.2 Million
Q3 2018 Nov 14, 2018	BUY	$351.14 - $408.51 $7.46 Million - $8.68 Million	21,238 Added 235.04%	30,274 $12.2 Million
Q2 2018 Aug 14, 2018	SELL	$284.6 - $344.99 $47 Million - $57 Million	-165,138 Reduced 94.81%	9,036 $3.12 Million
Q1 2018 May 15, 2018	SELL	$315.82 - $393.78 $9.6 Million - $12 Million	-30,383 Reduced 14.85%	174,174 $60 Million
Q4 2017 Feb 14, 2018	BUY	$358.63 - $469.95 $73.4 Million - $96.1 Million	204,557	204,557 $76.9 Million

Others Institutions Holding REGN

# of Institutions

1,471

Shares Held

85.8M

Call Options Held

1.39M

Put Options Held

1.45M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $52.6B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Account

Balyasny Asset Management LLC Regeneron Pharmaceuticals, Inc. Transaction History